These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6239164)

  • 21. Acute phase proteins and C9 in patients with Behcet's syndrome and aphthous ulcers.
    Adinolfi M; Lehner T
    Clin Exp Immunol; 1976 Jul; 25(1):36-9. PubMed ID: 1086750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased solubilization of immune complexes by the sera from patients with Behcet's disease.
    Tanaka K; Kajiyama K; Kameda S; Nishigouri S; Yamada I; Sawae Y
    Tohoku J Exp Med; 1983 Aug; 140(4):363-8. PubMed ID: 6636135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C-type lectin domain family 12, member A: A common denominator in Behçet's syndrome and acute gouty arthritis.
    Oğuz AK; Yılmaz S; Akar N; Özdağ H; Gürler A; Ateş A; Oygür ÇŞ; Kılıçoğlu SS; Demirtaş S
    Med Hypotheses; 2015 Aug; 85(2):186-91. PubMed ID: 25957656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The mechanism of hyperchemotaxis in Behçet's disease.
    Takeuchi A; Kobayashi K; Mori M; Mizushima Y
    J Rheumatol; 1981; 8(1):40-4. PubMed ID: 7218257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormalities of T-cell subsets in Behçet's syndrome.
    Lim SD; Haw CR; Kim NI; Fusaro RM
    Arch Dermatol; 1983 Apr; 119(4):307-10. PubMed ID: 6220679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-Saccharomyces cerevisiae antibody in intestinal Behçet's disease patients: relation to clinical course.
    Choi CH; Kim TI; Kim BC; Shin SJ; Lee SK; Kim WH; Kim HS
    Dis Colon Rectum; 2006 Dec; 49(12):1849-59. PubMed ID: 17080284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A study of antiendothelial cell antibodies in Behcet's disease].
    Zheng WJ; Zhao Y; Tang FL; Dong Y
    Zhonghua Nei Ke Za Zhi; 2005 Dec; 44(12):910-3. PubMed ID: 16409728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An immunogenetic basis for the tissue involvement in Behçet's syndrome.
    Lehner T; Batchelor JR; Challacombe SJ; Kennedy L
    Immunology; 1979 Aug; 37(4):895-900. PubMed ID: 500134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating immune complexes in Behçet's syndrome: purification, characterization and cross-reactivity studies.
    Valesini G; Picardo M; Pastore R; Pivetti P; Serafini U
    Clin Exp Immunol; 1981 Jun; 44(3):522-7. PubMed ID: 6976862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Plasma coagulation and fibrinolysis parameters in patients with vascular Behçet's disease, and analysis of the multimeric structure of von Willebrand factor (vWF)].
    Kagawa H; Okubo S
    Ryumachi; 1993 Oct; 33(5):416-23. PubMed ID: 8256164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating immune complexes in Behçet's disease.
    Inoue T; Oniki S; Kajiyama K; Jimi S
    Jpn J Ophthalmol; 1983; 27(1):35-9. PubMed ID: 6602236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-bacterial antibodies in Behçet's disease.
    Iannone F; Lapadula G; De Bari C; Covelli M; Pipitone V
    Clin Exp Rheumatol; 1997; 15(4):451-2. PubMed ID: 9272312
    [No Abstract]   [Full Text] [Related]  

  • 33. Absence of lupus anticoagulants in Behçet's disease.
    Bang D; Ji HG; Choi YS; Lee S
    Yonsei Med J; 1991 Dec; 32(4):326-9. PubMed ID: 1812653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ocular involvement in Behçet's disease.
    Peplinski LS
    J Am Optom Assoc; 1989 Nov; 60(11):854-7. PubMed ID: 2607080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New perspective on Behçet's disease.
    Sakane T
    Int Rev Immunol; 1997; 14(1):89-96. PubMed ID: 9203029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behçet's syndrome: pathogenesis, diagnosis, and treatment.
    Jorizzo JL
    Cutis; 1983 Nov; 32(5):441-5, 448. PubMed ID: 6653169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Etiopathology of Behçet's disease: immunological aspects.
    Sakane T; Suzuki N; Nagafuchi H
    Yonsei Med J; 1997 Dec; 38(6):350-8. PubMed ID: 9509903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Behçet's disease. Circulating immune complexes and abnormalities of polynuclear chemotaxis].
    Graisely B; Margueritte-Renard O; Cloarec M; Debray J
    Nouv Presse Med; 1979 Mar; 8(11):867. PubMed ID: 450661
    [No Abstract]   [Full Text] [Related]  

  • 39. Cell-mediated immune functions and immunoregulatory cells in Behçet's syndrome.
    Victorino RM; Ryan P; Hughes GR; Hodgson HJ
    Clin Exp Immunol; 1982 Apr; 48(1):121-8. PubMed ID: 6211313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies of the mechanisms of human B-cell activation. IV. Abnormalities at the B-cell level in patients with Behçet's disease].
    Suzuki N; Sakane T; Takada S; Ueda Y; Murakawa Y; Tsunematsu T; Tsuchiya T; Niwa Y
    Ryumachi; 1985 Apr; 25(2):95-102. PubMed ID: 3875902
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.